He didn’t shoot it down:
I believe there are ways we could do it. There are ways that could be destructive and distracting to the user experience. But there are ways that could potentially balance user experience with advertiser experience. We haven’t put a product out yet because we haven’t had one we’re comfortable with. But if we could, then we would do it.
Sure, it seems as if Fischer realizes that auto-play ads as they are commonly presented now would be disastrous. However, even considering it can be dangerous. Facebook users have forgiven the never-ending site redesigns, but they would be hard-pressed to come back to Facebook if it starts firing multimedia ads at them when they’re used to silent and uncluttered newsfeeds.
5. Game of thorns
Sony Corporation (ADR) (NYSE:SNE) held a media event to introduce its new video game console.
However, there was no console to show. During the entire two-hour presentation, Sony failed to actually show what the console — which will roll out later this year — actually looks like. It also failed to reveal the price tag.
Sony’s last console was priced too high, and given the past three years of slumping video game sales and Sony’s slipping market share, one would think that Sony would want that information out there if it’s serious about winning back the gaming community.
Yes, Sony did put out the specs. The features are great, though the shift to new architecture means that older games on disc won’t be playable on the PS4. Sony has a cloud-based workaround, but it’s going to be hard to convince early adopters to shell out big bucks for a brand-new platform given Sony’s recent shortcomings.
The article This Week’s 5 Dumbest Stock Moves originally appeared on Fool.com and is written by Rick Aristotle Munarriz.
Longtime Fool contributor Rick Aristotle Munarriz owns shares of Ebix. The Motley Fool recommends Ebix and Facebook. The Motley Fool owns shares of Ebix and Facebook.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.